The exact etiology of AD is still not fully understood, however, ample evidence points to amyloid-beta peptide (Aβ) as a key player in the pathogenesis of AD and is the earliest lesion in the disease process (Hardy and Higgins, 1992; Ballard et al., 2011). This evidence concerns the gene APP and Alzheimer disease.